Inventor · disambiguated record
Kexue Li
Also filed as: LI KEXUE
19 granted patents·12 pending applications·83 citations·filing 2003–2025
92Inventor score
Top patents by PatentIndex Score
31 records- 0197US10300075B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted May 28, 2019·22 cites·39 claims
- 0293US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 0391US10500213B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Dec 10, 2019·6 cites·46 claims
- 0489US12054476B2KIF18A inhibitorsAMGEN INC·Filed 2021·Granted Aug 6, 2024·1 cites·31 claims
- 0585US12509442B2KIF18A inhibitorsAMGEN INC·Filed 2024·Granted Dec 30, 2025·0 cites·32 claims
- 0683US7244727B2Fused bicyclic nitrogen-containing heterocyclesJAPAN TOBACCO INC·Filed 2003·Granted Jul 17, 2007·22 cites·57 claims
- 0781US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 0880US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 0978US7300932B2Pyrrolo[1,2-b]pyridazine derivativesJAPAN TOBACCO INC·Filed 2004·Granted Nov 27, 2007·14 cites·17 claims
- 1076US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 1175US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 1275US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 1375US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 1472US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 1569US12091425B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2021·Granted Sep 17, 2024·0 cites·7 claims
- 1669US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 1769US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 1865US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 1955US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 2055US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 2154US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 2254US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 2354US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 2454US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 2552US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2652US2024101570A1Tricyclic carboxamide derivatives as prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2752US2007244096A1Fused Bicyclic Nitrogen-Containing HeterocyclesJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 2851US2011086834A1Alkynyl alcohols as kinase inhibitorsAMGEN INC·Filed 2009·Application pending·0 cites
- 2949US11364248B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2018·Granted Jun 21, 2022·0 cites·45 claims
- 3048US12441705B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·0 cites·34 claims
- 3148US11279712B2Macrocyclic compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Mar 22, 2022·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Kexue Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →